CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Barcelona, Spain and 83 other locations
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
Barcelona, Spain and 76 other locations
compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...
Phase 2
Barcelona, Spain and 24 other locations
12 years old with moderate to severe asthma....
Phase 2
Barcelona, Catalunya, Spain and 20 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
Barcelona, Barcelona [Barcelona], Spain and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Barcelona, Spain and 114 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Barcelona, Catalunya, Spain and 51 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Barcelona, Spain and 92 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Barcelona, Spain and 158 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Barcelona, Barcelona [Barcelona], Spain and 52 other locations
Clinical trials
Research sites
Resources
Legal